-- 
Drug Royalty Drops $155 Million Term Loan to Refinance Debt

-- B y   M i c h a e l   A m a t o
-- 
2011-10-19T14:16:19Z

-- http://www.bloomberg.com/news/2011-10-19/drug-royalty-drops-155-million-term-loan-to-refinance-debt.html
Drug Royalty II, a fund managed by
Toronto-based DRI Capital, canceled a $155 million  term loan  it
was seeking to refinance debt because of market conditions,
according to a person with knowledge of the transaction.  Macquarie Group Ltd. was arranging the five-year
transaction, according to data compiled by Bloomberg. The loan
was initially offered to investors at 4.5 percentage points more
than the London interbank offered rate with a 1.25 percent Libor
floor. The debt was expected to price at 99 cents to 99.5 cents
on the dollar, said the person, who declined to be identified
because the terms are private.  Behzad Khosrowshahi, chief executive officer of DRI
Capital, didnâ€™t respond to an e-mail seeking comment.  To contact the reporter on this story:
Michael Amato in New York at 
 Mamato3@bloomberg.net   To contact the editor responsible for this story:
Faris Khan at 
 fkhan33@bloomberg.net  